What is New Lantern?
New Lantern offers advanced AI-powered cloud-native PACS solutions designed for healthcare providers, enhancing the speed and accuracy of radiology diagnostics. Their platform features tools such as Smart Worklist, PACS Viewer, and AI Reporter, which automate various aspects of radiology reporting and analysis. Targeting radiologists and healthcare institutions, New Lantern aims to reduce busywork and improve diagnostic confidence through efficient automation. The company is recognized for its responsive support and cost-effective solutions, making it a trusted partner in the radiology field.
How much funding has New Lantern raised?
New Lantern has raised a total of $19M across 1 funding round:
Series A
$19M
Series A (2024): $19M with participation from Benchmark
Key Investors in New Lantern
Benchmark
Benchmark is a venture capital firm based in San Francisco that provides seed money to startups. The firm's most successful investment was a 1997 investment of $6.7 million in eBay for 22.1% of the company. In 2011, it invested $12 million for an 11% stake in Uber, worth $7 billion in 2019.
What's next for New Lantern?
The recent major strategic investment signals a period of accelerated growth and market expansion for New Lantern. This capital infusion is expected to fuel further development of their AI diagnostic tools and broaden their reach within the healthcare sector. The company's focus on automation and diagnostic confidence positions it for significant impact in the radiology landscape, potentially leading to further enterprise-level funding rounds as they scale their operations and client base.
See full New Lantern company page
